Syngene International Ltd vs Unihealth Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Syngene International Ltd is ₹ 366.9 as of 23 Oct 15:30 . The P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 yearsThe P/E Ratio of Unihealth Hospitals Ltd changed from 20.2 on March 2024 to 22 on March 2026 . This represents a CAGR of 2.89% over 3 years The Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 yearsThe Market Cap of Unihealth Hospitals Ltd changed from ₹ 207.9 crore on March 2024 to ₹ 568.97 crore on March 2026 . This represents a CAGR of 39.88% over 3 years The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The revenue of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The ebitda of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Unihealth Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 yearsThe Dividend Payout of Unihealth Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

About Unihealth Hospitals Ltd

Unihealth Consultancy Limited was incorporated as Private Limited Company under the name 'Unihealth Consultancy Private Limited', Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on February 26, 2010.
The Company status changed to Public Limited, and its name was changed to 'Unihealth Consultancy Limited' dated April 26, 2023 issued by the Registrar of Companies, Mumbai. Unihealth Consultancy Limited is the Holding Company of the Group providing healthcare consultancy and management services.
The Company facilitates medical value travel for patients travelling from various countries into Middle East and Africa to India for advanced medical care services.
The Company is a healthcare service provider based out of Mumbai, India having operational presence in multiple countries across the African continent.

FAQs for the comparison of Syngene International Ltd and Unihealth Hospitals Ltd

Which company has a larger market capitalization, Syngene International Ltd or Unihealth Hospitals Ltd?

Market cap of Syngene International Ltd is 14,810 Cr while Market cap of Unihealth Hospitals Ltd is 787 Cr

What are the key factors driving the stock performance of Syngene International Ltd and Unihealth Hospitals Ltd?

The stock performance of Syngene International Ltd and Unihealth Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syngene International Ltd and Unihealth Hospitals Ltd?

As of October 25, 2026, the Syngene International Ltd stock price is INR ₹366.9. On the other hand, Unihealth Hospitals Ltd stock price is INR ₹495.5.

How do dividend payouts of Syngene International Ltd and Unihealth Hospitals Ltd compare?

To compare the dividend payouts of Syngene International Ltd and Unihealth Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.